Case Study: Non-secretory Multiple Myeloma with Eosinophilia - Diagnostic Hurdles and a Comprehensive Literature Review - Top-Institutions - MDSpire

Case Study: Non-secretory Multiple Myeloma with Eosinophilia - Diagnostic Hurdles and a Comprehensive Literature Review

By
Jirui Zhong
Xikun Liu
Jiduo Liu
Shanshan Xiao
Xuekui Gu
Zenghui Liu
April 22, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Hematology
- Oncology
- Plasma Cell Disorders
#2

Mayo Clinic

Rochester, MN
Key Differentiators
- Hematology
- Oncology
- Multiple Myeloma
#3

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Hematology
- Oncology
- Plasma Cell Disorders
#4

University of Arkansas for Medical Sciences (UAMS)

Little Rock, AR
Key Differentiators
- Hematology
- Oncology
- Multiple Myeloma Research

Original Source(s)

Frontiers In Oncology

Case Study: Non-secretory Multiple Myeloma with Eosinophilia - Diagnostic Hurdles and a Comprehensive Literature Review

by Jirui Zhong, Xikun Liu, Jiduo Liu, Shanshan Xiao, Xuekui Gu, Zenghui Liu
April 22, 2026

Related Content

Bmc Cancer

Efficacy of Quadruplet Therapy with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone as Initial Treatment for High-Risk Multiple Myeloma Patients in China: Findings from a Multi-Center Real-World Study

Frontiers In Surgery

Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma

by Jakub Halámek, Ivan Špička, Zdeněk Krška, Kristian Chrz
May 20, 2026

Frontiers In Oncology

Combination of Lisaftoclax, Ixazomib, and Dexamethasone for Maintenance Therapy Following CAR-T in Patients with Transplant-Ineligible Relapsed/Refractory Ultra-High-Risk Multiple Myeloma: A Review of Two Cases and Relevant Literature

by Weige Xu, Xue Qiao, Linlin Zhang, Lina Xing, Jingnan Zhang, Xiaonan Guo, Shukai Qiao
April 28, 2026